AtriCure, Inc. (ATRC) stock

ATRCNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 12/30611% above fair value

$56.84+0.86 (+1.54%)

Close on Nov 13, 2026Market cap $2.89BP/E 189.5Yield –

AtriCure EV/EBITDA

EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.

AtriCure's EV/EBITDA was 218.7× on Nov 11, 2026, against 56.8× a year earlier.

Period	Period end	Value	Change (pts)
2026	Nov 11, 2026	218.7×	+186.2
2022	Oct 31, 2022	32.5×	−29.8
2021	Dec 31, 2021	62.4×	–

Trailing twelve months. Peers are matched on business description, industry and size. Ticks are peers, the dot is ATRC.

Revenue growth13.8% · median 11.8%

Gross margin76.7% · median 68.7%

Operating margin2.9% · median 2.3%

Net margin2.5% · median -3.7%

Advertisement
300 × 250

See a number that looks wrong?